Asia Pacific Blood Glucose Monitoring Market Highlights
Several devices for testing the glucose level in the blood are available in the market such as invasive glucose monitoring devices, continuous glucose monitoring devices (CGM), and flash glucose monitoring devices. These devices are designed according to the type of diabetes, which help to identify the blood glucose level within the specified target range and hence help you to track your diet accordingly. Growing awareness regarding the devices in developing countries has fuelled the demand for these devices in Asia Pacific region.
According to the American Diabetes Association, the blood glucose levels for an adult without diabetes is below 100 mg/dl before meals and fasting and is less than 140 mg/dl two hours after a meal.
Diabetes is one of the leading causes of premature death and disability. It can be managed effectively if it diagnosed at early stage. However, if left untreated, it can lead to various complications such as heart disease, stroke, kidney damage, and nerve damage.
The Asia Pacific Blood Glucose Monitoring market size is expected to reach USD 2,041.6 Million by 2030 at CAGR 13.6% during the forecast period 2022-2030.
Regional Analysis
China dominates the Asia Pacific blood glucose monitoring market owing to well-developed technology, increasing patient population with diabetes, high health care spending, and increasing government support for research & development. According to WHO, 110 million people have with diabetes in China.
India is the second leading country having many diabetic patient populations in Asia Pacific. According to International Diabetes Federation, over 69.1 million people in 2015 had diabetes in India. Diabetes is one of the major diseases in India. Over 50 million people have diabetes in India.
Furthermore, countries such as Japan, Australia, and the Republic of Korea are showing a considerable growth in the blood glucose monitoring market.
However, increasing awareness, and development of the treatment technology is fuelling the demand for the blood glucose monitoring devices in countries like South Korea and India.
Segmentation
The Asia Pacific blood glucose monitoring devices market outlook is segmented based on product type, application, and end user.
Based on the product type, it is segmented into invasive glucose monitoring devices, continuous glucose monitoring devices (CGM), flash glucose monitoring devices, and self-monitoring blood glucose meter.
Based on the application, it is segmented into type 1 diabetes, type 2 diabetes, and others.
Based on the end user, it is segmented into diagnostic centres, hospitals, clinics, research centres, and home care diagnostics.
Asia Pacific Blood Glucose Monitoring Market Players
Asia Pacific blood glucose monitoring market players are Abbott Laboratories, Arkay, Inc., Bayer Healthcare AG, F. Hoffmann-La Roche, Goldsite Diagnostics Inc., GlySure Ltd, Sphere Medical, Dexcom, Inc., and LifeScan.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
